Department of Environmental Health

 

Researcher
IKETANI Ryo

Specialty

Pharmacoepidemiology, Medical statistics, Meta-analysis, real-world data, evaluation of pharmacist ability

Works

Original papers

1 Iketani R, Imai S. Prescription trends for the antidiabetic agents used to treat type 2 diabetes mellitus in Japan from 2012–2020: a time-series analysis. Biol Pharm Bull 2023;46:592-598.

2 Iketani R, Imai S. Impact of breakthrough trials on prescription trends of sodium‐glucose cotransporter‐2 inhibitors in Japan: An interrupted time‐series analysis. J Clin Pharm Ther 2022;47:1796-1804.

3 Iketani R, Konomura K. Identification of individuals benefiting from the kakaritsuke-yakuzaishi (family pharmacist) system in Japan: a retrospective cohort study using an employment-based health insurance claims database. BMC Health Serv Res 2022;22:1-11.

4 Iketnai R, Konomura K. Utility of the family pharmacist system: a retrospective cohort study using administrative claims data [in Japanese]. Jpn J Pharm Health Care Sci. 2021;47:453–63.

5 Iketnai R, Konomura K. Identification of patients with type 2 diabetes mellitus requiring concentrated pharmaceutical management in health insurance pharmacies: quantitative evaluation using administrative claims data [in Japanese]. Jpn J Pharm Health Care Sci. 2021;47:10-24.

6 Iketani R, Furushima D, Imai S, Yamada H. Efficacy and safety of atypical antipsychotics for psychosis in Parkinson’s disease: A systematic review and Bayesian network meta-analysis. Parkinsonism Relat Disord 2020;78:82-90.

7 Iketani R, Imai S, Horiguchi H, Furushima D, Fushimi K, Yamada H. Risk stratification for physical morbidity using factors associated with atypical antipsychotic treatment in Parkinson’s disease: A retrospective observational study using administrative claims data. J Clin Neurosci 2020;76:189-94.

8 Iketani R, Imai S, Horiguchi H, Furushima D, Fushimi K, Yamada H. Comparison of the association of risperidone and quetiapine with deteriorating performance in walking and dressing in subjects with Parkinson’s disease: a retrospective cohort study using administrative claims data. Int Clin Psychopharmacol 2019;34(5):234-40.

9 Iketani R, Ide K, Yamada H, Kawasaki Y, Masaki N. Regional Differences in the Safety of Telaprevir-Based Triple Therapy for Chronis Hepatitis C in Japan: A Retrospective Pilot Cohort Study. Jpn J Drug Infom 2018;20(2):57-65.

10 Iketani R, Ohno K, Kawasaki Y, Matsumoto K, Yamada H, Kishino S. Apolipoprotein E Gene Polymorphisms Affect the Efficacy of Thiazolidinediones for Alzheimer’s Disease: A Systematic Review and Meta-analysis. Biol Pharm Bull 2018;41(7):1017-23.

Others(Awards, etc.)

The 16th Annual Meeting of the Pharmacy Society of Japan, Excellent Presentation Award

The 31st Annual Meeting of the Japanese Society of Pharmaceutical Health Care and Sciences, Young Investigator’s Award

The 134th Annual Meeting of the Pharmaceutical Society of Japan, Excellent Presentation Award